Your browser doesn't support javascript.
loading
An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma.
Izutsu, Koji; Makita, Shinichi; Nosaka, Kisato; Yoshimitsu, Makoto; Utsunomiya, Atae; Kusumoto, Shigeru; Morishima, Satoko; Tsukasaki, Kunihiro; Kawamata, Toyotaka; Ono, Takaaki; Rai, Shinya; Katsuya, Hiroo; Ishikawa, Jun; Yamada, Hironori; Kato, Kazunobu; Tachibana, Masaya; Kakurai, Yasuyuki; Adachi, Nobuaki; Tobinai, Kensei; Yonekura, Kentaro; Ishitsuka, Kenji.
Affiliation
  • Izutsu K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Makita S; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Nosaka K; Department of Hematology, Rheumatology and Infectious Diseases, Kumamoto University Hospital, Kumamoto, Japan.
  • Yoshimitsu M; Department of Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima, Japan.
  • Utsunomiya A; Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
  • Kusumoto S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Morishima S; Division of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology, Second Department of Internal Medicine, Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan.
  • Tsukasaki K; Department of Hematology, International Medical Center, Saitama Medical University, Saitama, Japan.
  • Kawamata T; Department of Hematology/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Ono T; Department of Transfusion and Cell Therapy, Hamamatsu University Hospital, Shizuoka, Japan.
  • Rai S; Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Osaka, Japan.
  • Katsuya H; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
  • Ishikawa J; Department of Hematology, Osaka International Cancer Institute, Osaka, Japan.
  • Yamada H; Daiichi Sankyo Co, Ltd, Tokyo, Japan.
  • Kato K; Daiichi Sankyo, Inc, Basking Ridge, NJ.
  • Tachibana M; Daiichi Sankyo Co, Ltd, Tokyo, Japan.
  • Kakurai Y; Daiichi Sankyo Co, Ltd, Tokyo, Japan.
  • Adachi N; Daiichi Sankyo Co, Ltd, Tokyo, Japan.
  • Tobinai K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Yonekura K; Department of Dermatology, Imamura General Hospital, Kagoshima, Japan.
  • Ishitsuka K; Department of Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima, Japan.
Blood ; 141(10): 1159-1168, 2023 03 09.
Article in En | MEDLINE | ID: mdl-36150143
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombocytopenia / Leukemia-Lymphoma, Adult T-Cell / Lymphoma / Lymphopenia / Neutropenia Limits: Adult / Aged / Humans Language: En Journal: Blood Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombocytopenia / Leukemia-Lymphoma, Adult T-Cell / Lymphoma / Lymphopenia / Neutropenia Limits: Adult / Aged / Humans Language: En Journal: Blood Year: 2023 Document type: Article Affiliation country: Country of publication: